LEADER 05403nam 2200649 450 001 9910131472003321 005 20210603001424.0 010 $a1-118-84619-2 010 $a1-118-84621-4 010 $a1-118-84620-6 035 $a(CKB)3710000000476377 035 $a(EBL)4039212 035 $a(SSID)ssj0001553100 035 $a(PQKBManifestationID)16171379 035 $a(PQKBTitleCode)TC0001553100 035 $a(PQKBWorkID)14813119 035 $a(PQKB)11358207 035 $a(PQKBManifestationID)16176019 035 $a(PQKB)21181626 035 $a(MiAaPQ)EBC4039212 035 $a(DLC) 2015012590 035 $a(Au-PeEL)EBL4039212 035 $a(CaPaEBR)ebr11112843 035 $a(CaONFJC)MIL831286 035 $a(OCoLC)905802006 035 $a(PPN)194583945 035 $a(EXLCZ)993710000000476377 100 $a20151104h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aStem cells in regenerative medicine $escience, regulation and business strategies /$fedited by Alain A. Vertes [and three others] ; contributors, Timothy E. Allsopp [and sixty others] 210 1$aChichester, England :$cWiley Blackwell,$d2015. 210 4$dİ2015 215 $a1 online resource (1202 p.) 300 $aDescription based upon print version of record. 311 $a1-119-97139-X 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aTherapeutic stem cells answer a strategic breakthrough need of healthcare / Alain Vertes -- Ethical considerations on the research and business of stem cells / Ljiljana Minwalla -- Projected growth of the worldwide stem cell market / Ed Field -- Cell therapy manufacturing: identifying and meeting demand / Jessica Carmen, David A. Brindley, Natasha L. Davie and David Smith -- The history of stem cell transplantation / Hilliard M. Lazarus and Stan Gerson -- Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a U.S. perspective / Michael Mendicino and Darin Weber -- The regulation of stem cells in the UK and EU / Alex Denoon, Julian Hitchcock and James Lawford Davies -- The business of stem cell research tools / Erik Miljan -- Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications / Kate Camerona, Howard Marriage, David Haya and Claire Medine -- Stem cell tools for compound development / Tom Novak -- Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine / Vinagolu K. Rajasekhar -- The market of stem cell medicines for domestic and high value animals / Bob J. Harmann -- Stem cells veterinary medicines: a conceptual approach / John Peroni and Lindsey Boone -- Stem cells in veterinary medicines: a practical approach / Bob J. Harmann -- Stem cell veterinary medicines as success signals towards human stem cell therapeutics / Alain Vertes -- Animal models in regenerative medicine / Andrew N. Bubak, John D. Elsworth and John R. Sladek, Jr. -- Stem cell characterization: a guide to stem cell types, technologies, and future applications / Justin Lo Re, Rezma Shrestha and Leonard Sciorra -- Stem cell value chains / Judy Muller-Cohn, Paul Diaz and Rolf Muller -- Stem cell culture processes / Ravali Raju, Shikha Sharma and Wei-Shou Hu -- Indication transformation maps and the challenge of live cells delivery / Bob Deans and Lee Babiss -- Delivery and targeting of therapeutic cells / Paul Lin, Arnold I. Caplan and Erkki Ruoshlati -- Hematopoietic stem cells / Steve Wolpe and Lynnet Koh -- MSCs: the new medicince / Arnold Caplan -- Innovation and commercialization of induced pluripotent stem cells / Shintaro Sengoku -- Embryonic stem cells / Rachel Eiges, Benjamin E. Reubinoff and Charles Irving -- Allogeneic versus autologous stem cell transplantation in regenerative medicine / Kathy Trzaska-Accurso and Pranela Rameshwar -- Clinical immunological barriers to regenerative medicine: do they matter? / Cristina Trento and Francesco Dazzi -- Challenges in the clinical development of stem cells / John Caulfield -- Pricing and reimbursement of regenerative medicines / Nathan Dowden -- The role of patient advocacy in the clinical translation of regenerative medicine / Bernard Siegel and Alan Jakimo -- Financing strategies for regenerative medicine start-ups / Carol Julie Walton, Lee Buckler and Gregory A. Bonfiglio -- Strategic alliances, mergers and acquisitions in regenerative medicine / Nafees N. Malik, Timothy E. Allsopp and Devyn M. Smith -- History of monoclonal antibodies and lessons for the development of stem cell therapeutics / Alain Vertes and Nathan Dowden -- Deployment of stem cell technologies in industry and healthcare/ Alain Vertes. 606 $aStem cells 606 $aRegenerative medicine 615 0$aStem cells. 615 0$aRegenerative medicine. 676 $a616.02/774 701 $a?Rajasekhar$b ?Vinagolu K$pMSKCC.$0879114 702 $aVertes$b Alain A. 702 $aAllsopp$b Timothy E. 712 02$aMemorial Sloan Kettering Cancer Center (MSKCC). 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910131472003321 996 $aStem cells in regenerative medicine$92033563 997 $aUNINA